<DOC>
	<DOCNO>NCT02284503</DOCNO>
	<brief_summary>This 30-day , randomize , open-label , 3-arm , parallel-group , multicenter study explore efficacy intensive rosuvastatin treatment peri-PCI Chinese patient NSTE-ACS .</brief_summary>
	<brief_title>Exploring Efficacy Intensive Rosuvastatin Treatment Peri-PCI Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome ( NSTE-ACS )</brief_title>
	<detailed_description>Non ST-segment elevate acute coronary syndrome ( NSTE-ACS ) increase rapidly , frequent ST-segment elevate acute coronary syndrome ( STE-ACS ) . NSTE-ACS patient send early PCI procedure large increase rapidly China.Quite trial focus high load dose statin PCI improve cardiovascular outcome ACS . In Asian , high load dose statin therapy show different outcome . Rosuvastatin ( RSV ) one potent statins.Nowadays , quite expert think ACS patient undergo PCI need load dose statin , also post PCI intensive statin treatment rather important . Chinese consensus western guideline recommend intensive statin treatment patient . However , Chinese consensus refer western study 's relevant intensive statin treatment peri-PCI study China . Thus study design explore efficacy intensive statin treatment peri-PCI ( early load dose-RSV 40 mg 20mg PCI subsequent 20mg post PCI ) periprocedural myocardial injury 30 day MACE reduction Chinese NSTE-ACS patient explore efficacy 30-day RSV 20 mg post-PCI treatment lipid profile , inflammatory factor compare baseline .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . 1880 year old male nonchildbearing period female . 2 . Clinical diagnose NSTEACS , include unstable angina nonSTsegment elevation myocardial infarction ( NSTEMI ) . For unstable angina , diagnose meet : Clinical onset feature : angina least 20 min resting ; initial onset angina pectoris ( new onset within one month ) manifest spontaneous angina labor angina ( CCS grade II III ) ; Symptoms original stable angina pectoris aggravate one month least achieve CCS grade III ( accelerate angina pectoris ) ; angina onset within one month MI . ECG : At least twice one month : ST depression elevation &gt; 0.1millivolt ( mv ) Twave inversion ≥0.2 mv 2 contiguous electrocardiographic lead onset STT change recover remission chest pain . Myocardial damage marker elevate reach MI diagnostic level . For NSTEMI , diagnose meet ischemia symptom ( ischemic chest pain last 30 min relief significantly sublingual NTG ) ECG change : new STT dynamic development ( new transient ST depression ≥0.1mv Twave inversion≥0.2mv ) . Myocardial damage marker level normal elevate MI diagnostic level . 3 . Received early ( within 48 h ) Percutaneous Coronary Intervention ( PCI ) . 4 . Should statin naïve ( last 3 month ) . 5 . Only receive drugeluting stent . 6 . Sign Informed Consent Form ( ICF ) Any follow regard criterion exclusion study : 1 . Diagnosis STEMI ; 2 . NSTEACS highrisk feature warrant emergency coronary angiography ; 3 . Receive medical therapy Coronary Artery Bypass Graft ( CABG ) 4 . Active liver disease dysfunction include agnogenic serum transaminase sustain elevation high 3 time upper limit normal ( ULN ) ; 5 . Left ventricular ejection fraction＜30 % ; 6 . Previous current treatment statin ; 7 . Patients myopathy serum creatine kinase &gt; 5 time upper limit normal cause myocardial injury ; 8 . Severe renal function damage ( creatinine clearance rate &lt; 30 ml/min ) ; 9 . Severe anemia ( haemoglobin &lt; 6g/L ) ; 10 . Diagnosed malignancy within 5 year ; 11 . Concurrent use ciclosporin； 12 . Investigator evaluate appropriate statin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>MI reduction</keyword>
	<keyword>intensive statin treatment</keyword>
	<keyword>NSTE-ACS</keyword>
</DOC>